In today’s Pharmaceutical Executive Daily, Novo Nordisk files for FDA approval of a higher-dose Wegovy injectable using a ...

Eli Lilly reduced Zepbound vial prices for self-paying patients via LillyDirect, aiming to lower obesity treatment costs and ...

Pharmaceutical companies face distinct pricing and market access (P&MA) challenges in Korea and Australia, two of ...

The agency’s decision is based on claims that the Covid vaccine was linked to the deaths of 10 children.

Traditional hubs absorb friction; DTP eliminates it. API-driven orchestration replaces manual fax loops and opaque call trees with verified, timestamped steps that any stakeholder can audit. Providers ...

How has the rise of GLP-1s impacted businesses outside of pharma? Jay Bregman: Up until, the rise of these medications has ...

Psychedelics have demonstrated significant progress, generating enthusiasm across the neuroscience industry and leading to successful independent companies. Rare neuromuscular and neurodevelopmental ...

Psychedelics have demonstrated significant progress, generating enthusiasm across the neuroscience industry and leading to ...

In today’s Pharmaceutical Executive Daily, Novartis plans to eliminate 550 positions at a major Swiss site, the FDA authorizes the first gene therapy for adolescents and adults with spinal muscular ...

Psychedelics have demonstrated significant progress, with promising data and increased interest from large companies, ...

PE: How will FDA's Priority Review Program impact domestic manufacturing? Conrad: A company is not going to de novo set up a new US-based manufacturing site just for this voucher. They cost billions ...

Aidoc's multi-triage device, powered by the CARE Foundation Model, detects and prioritizes multiple abdominal conditions with ...